Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case.

Iesari S, Mocchegiani F, Nicolini D, Benedetti Cacciaguerra A, Coletta M, Montalti R, Mandolesi A, Lerut J, Vivarelli M.

Am J Transplant. 2019 Apr 3. doi: 10.1111/ajt.15377. [Epub ahead of print]

PMID:
30943317
2.

Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.

Moroncini G, Benfaremo D, Mandolesi A, Gabrielli A.

BMJ Case Rep. 2018 May 18;2018. pii: bcr-2018-224829. doi: 10.1136/bcr-2018-224829.

PMID:
29776943
3.

Are liver nested stromal epithelial tumors always low aggressive?

Meletani T, Cantini L, Lanese A, Nicolini D, Cimadamore A, Agostini A, Ricci G, Antognoli S, Mandolesi A, Guido M, Alaggio R, Giuseppetti GM, Scarpelli M, Vivarelli M, Berardi R.

World J Gastroenterol. 2017 Dec 14;23(46):8248-8255. doi: 10.3748/wjg.v23.i46.8248.

4.

ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation.

Rostami K, Marsh MN, Johnson MW, Mohaghegh H, Heal C, Holmes G, Ensari A, Aldulaimi D, Bancel B, Bassotti G, Bateman A, Becheanu G, Bozzola A, Carroccio A, Catassi C, Ciacci C, Ciobanu A, Danciu M, Derakhshan MH, Elli L, Ferrero S, Fiorentino M, Fiorino M, Ganji A, Ghaffarzadehgan K, Going JJ, Ishaq S, Mandolesi A, Mathews S, Maxim R, Mulder CJ, Neefjes-Borst A, Robert M, Russo I, Rostami-Nejad M, Sidoni A, Sotoudeh M, Villanacci V, Volta U, Zali MR, Srivastava A.

Gut. 2017 Dec;66(12):2080-2086. doi: 10.1136/gutjnl-2017-314297. Epub 2017 Sep 11.

5.

Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.

Rossi S, Gasparotto D, Cacciatore M, Sbaraglia M, Mondello A, Polano M, Mandolesi A, Gronchi A, Reuss DE, von Deimling A, Maestro R, Dei Tos AP.

Mod Pathol. 2018 Jan;31(1):160-168. doi: 10.1038/modpathol.2017.105. Epub 2017 Sep 1.

6.

A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.

Bianchi F, Maccaroni E, Belvederesi L, Brugiati C, Giampieri R, Bini F, Bracci R, Pagliaretta S, Del Prete M, Piva F, Mandolesi A, Scarpelli M, Berardi R.

Fam Cancer. 2018 Apr;17(2):215-224. doi: 10.1007/s10689-017-0030-x.

PMID:
28785832
7.

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.

Demurtas L, Puzzoni M, Giampieri R, Ziranu P, Pusceddu V, Mandolesi A, Cremolini C, Masi G, Gelsomino F, Antoniotti C, Loretelli C, Meriggi F, Zaniboni A, Falcone A, Cascinu S, Scartozzi M.

Br J Cancer. 2017 Jul 25;117(3):315-321. doi: 10.1038/bjc.2017.178. Epub 2017 Jun 20.

8.

Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.

Nicolini D, Agostini A, Montalti R, Mocchegiani F, Mincarelli C, Mandolesi A, Robertson NL, Candelari R, Giovagnoni A, Vivarelli M.

World J Gastroenterol. 2017 May 28;23(20):3690-3701. doi: 10.3748/wjg.v23.i20.3690.

9.

Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome.

Fraticelli P, Bagnarelli P, Tarantino G, Martino GP, Benfaremo D, Nobili L, Mandolesi A, Barbisan F, Marinelli K, Mattioli M, Murri M, Gabrielli A.

Rheumatology (Oxford). 2016 Dec;55(12):2275-2277. Epub 2016 Aug 7. No abstract available.

PMID:
27498353
10.

Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

Gasparotto D, Rossi S, Polano M, Tamborini E, Lorenzetto E, Sbaraglia M, Mondello A, Massani M, Lamon S, Bracci R, Mandolesi A, Frate E, Stanzial F, Agaj J, Mazzoleni G, Pilotti S, Gronchi A, Dei Tos AP, Maestro R.

Clin Cancer Res. 2017 Jan 1;23(1):273-282. doi: 10.1158/1078-0432.CCR-16-0152. Epub 2016 Jul 7.

11.

Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.

Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP.

Oncotarget. 2016 May 24;7(21):30109-18. doi: 10.18632/oncotarget.8768.

12.

Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.

Giampieri R, Maccaroni E, Mandolesi A, Del Prete M, Andrikou K, Faloppi L, Bittoni A, Bianconi M, Scarpelli M, Bracci R, Scartozzi M, Cascinu S.

Gastric Cancer. 2017 Jan;20(1):156-163. doi: 10.1007/s10120-016-0594-4. Epub 2016 Jan 21.

PMID:
26796888
13.

KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma.

Bittoni A, Piva F, Santoni M, Andrikou K, Conti A, Loretelli C, Mandolesi A, Lanese A, Pellei C, Scarpelli M, Principato G, Cascinu S.

Future Oncol. 2015;11(13):1905-17. doi: 10.2217/fon.15.98.

PMID:
26161927
14.

HER family receptor expression and prognosis in pancreatic cancer.

Bittoni A, Mandolesi A, Andrikou K, Santoni M, Alfonsi S, Lanese A, Loretelli C, Pellei C, Piva F, Scarpelli M, Cascinu S.

Int J Biol Markers. 2015 Jul 22;30(3):e327-32. doi: 10.5301/jbm.5000157.

PMID:
26109364
15.

Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.

Giampieri R, Mandolesi A, Abouelkhair KM, Loretelli C, Del Prete M, Faloppi L, Maristella B, Ibrahim EM, Scarpelli M, Cascinu S, Scartozzi M.

J Transl Med. 2015 May 7;13:140. doi: 10.1186/s12967-015-0501-5.

16.

Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses.

Andrikou K, Santoni M, Piva F, Bittoni A, Lanese A, Pellei C, Conti A, Loretelli C, Mandolesi A, Giulietti M, Scarpelli M, Principato G, Falconi M, Cascinu S.

Future Oncol. 2015;11(7):1037-45. doi: 10.2217/fon.15.27.

PMID:
25804119
17.

Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review.

Gatti S, Rossi M, Alfonsi S, Mandolesi A, Cobellis G, Catassi C.

Front Med (Lausanne). 2014 May 2;1:9. doi: 10.3389/fmed.2014.00009. eCollection 2014. Review.

18.

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.

Scartozzi M, Faloppi L, Svegliati Baroni G, Loretelli C, Piscaglia F, Iavarone M, Toniutto P, Fava G, De Minicis S, Mandolesi A, Bianconi M, Giampieri R, Granito A, Facchetti F, Bitetto D, Marinelli S, Venerandi L, Vavassori S, Gemini S, D'Errico A, Colombo M, Bolondi L, Bearzi I, Benedetti A, Cascinu S.

Int J Cancer. 2014 Sep 1;135(5):1247-56. doi: 10.1002/ijc.28772. Epub 2014 Feb 20.

19.

Clinical evidence for three distinct gastric cancer subtypes: time for a new approach.

Bittoni A, Scartozzi M, Giampieri R, Faloppi L, Bianconi M, Mandolesi A, Del Prete M, Pistelli M, Cecchini L, Bearzi I, Cascinu S.

PLoS One. 2013 Nov 12;8(11):e78544. doi: 10.1371/journal.pone.0078544. eCollection 2013.

20.

Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.

Negri FV, Azzoni C, Bottarelli L, Campanini N, Mandolesi A, Wotherspoon A, Cunningham D, Scartozzi M, Cascinu S, Tinelli C, Silini EM, Ardizzoni A.

Anticancer Res. 2013 Oct;33(10):4611-7.

PMID:
24123038
21.

Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.

Scartozzi M, Giampieri R, Loretelli C, Bittoni A, Mandolesi A, Faloppi L, Bianconi M, Del Prete M, Andrikou K, Bearzi I, Cascinu S.

Pharmacogenomics. 2013 Dec;14(16):1991-8. doi: 10.2217/pgs.13.185. Epub 2013 Oct 3.

22.

Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.

Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M.

World J Gastroenterol. 2013 Sep 14;19(34):5622-32. doi: 10.3748/wjg.v19.i34.5622.

23.

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.

Giampieri R, Scartozzi M, Loretelli C, Piva F, Mandolesi A, Lezoche G, Del Prete M, Bittoni A, Faloppi L, Bianconi M, Cecchini L, Guerrieri M, Bearzi I, Cascinu S.

PLoS One. 2013 Sep 4;8(9):e72843. doi: 10.1371/journal.pone.0072843. eCollection 2013.

24.

Bilateral squamous cell carcinoma of the feet associated with human papillomavirus type 16 infection.

Campanati A, Dusi D, Conocchiari L, Brancorsini D, Mandolesi A, Grassetti L, Di Bendetto G, Offidani A.

Int J Dermatol. 2013 Dec;52(12):1608-9. doi: 10.1111/j.1365-4632.2012.05466.x. Epub 2013 Jun 7. No abstract available.

PMID:
23742630
25.

Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab.

Scartozzi M, Giampieri R, Loretelli C, Mandolesi A, del Prete M, Biagetti S, Alfonsi S, Faloppi L, Bianconi M, Bittoni A, Bearzi I, Cascinu S.

Future Oncol. 2013 Aug;9(8):1207-14. doi: 10.2217/fon.13.72. Epub 2013 Apr 26.

PMID:
23617461
26.

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.

Scartozzi M, Loretelli C, Galizia E, Mandolesi A, Pistelli M, Bittoni A, Giampieri R, Faloppi L, Bianconi M, Del Prete M, Bianchi F, Belvederesi L, Bearzi I, Cascinu S.

PLoS One. 2012;7(7):e38192. doi: 10.1371/journal.pone.0038192. Epub 2012 Jul 9.

27.

Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis.

Patrignani A, Purcaro A, Calcagnoli F, Mandolesi A, Bearzi I, Ciampani N.

J Cardiovasc Med (Hagerstown). 2014 Nov;15(11):828-33. doi: 10.2459/JCM.0b013e328354e473. Review.

PMID:
22710763
28.

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.

Scartozzi M, Giampieri R, Maccaroni E, Mandolesi A, Biagetti S, Alfonsi S, Giustini L, Loretelli C, Faloppi L, Bittoni A, Bianconi M, Del Prete M, Bearzi I, Cascinu S.

J Transl Med. 2012 Apr 10;10:71. doi: 10.1186/1479-5876-10-71.

29.

Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy.

Berardi R, Maccaroni E, Mandolesi A, Mantello G, Onofri A, Biscotti T, Pierantoni C, Siquini W, Marmorale C, Guerrieri M, Bearzi I, Cascinu S.

Dig Liver Dis. 2012 Jul;44(7):617-22. doi: 10.1016/j.dld.2012.02.006. Epub 2012 Mar 21.

PMID:
22440241
30.

Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.

Scartozzi M, Giampieri R, Maccaroni E, Mandolesi A, Giustini L, Silva R, Zaniboni A, Biscotti T, Biagetti S, Galizia E, Loupakis F, Falcone A, Bearzi I, Cascinu S.

Ann Oncol. 2012 Jul;23(7):1706-12. doi: 10.1093/annonc/mdr558. Epub 2011 Nov 23.

PMID:
22112971
31.

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.

Scartozzi M, Bearzi I, Mandolesi A, Giampieri R, Faloppi L, Galizia E, Loupakis F, Zaniboni A, Zorzi F, Biscotti T, Labianca R, Falcone A, Cascinu S.

Br J Cancer. 2011 May 24;104(11):1786-90. doi: 10.1038/bjc.2011.161. Epub 2011 May 10.

32.

Adenocarcinoma arising from ileoanal J-pouch mucosa: an announced event?

Marmorale C, Stortoni P, Siquini W, Scartozzi M, Berardi R, Mandolesi A, Bearzi I, Fianchini A.

Inflamm Bowel Dis. 2011 Jun;17(6):E57-8. doi: 10.1002/ibd.21711. Epub 2011 Apr 6. No abstract available.

PMID:
21472828
33.

Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies.

Alarida K, Harown J, Ahmaida A, Marinelli L, Venturini C, Kodermaz G, Tozzoli R, Mandolesi A, Bearzi I, Catassi C.

Dig Liver Dis. 2011 Sep;43(9):688-91. doi: 10.1016/j.dld.2011.01.002. Epub 2011 Feb 9.

PMID:
21310672
34.

The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.

Scartozzi M, Mandolesi A, Giampieri R, Bittoni A, Pierantoni C, Zaniboni A, Galizia E, Giustini L, Silva RR, Bisonni R, Berardi R, Biscotti T, Biagetti S, Bearzi I, Cascinu S.

Oncologist. 2011;16(1):53-60. doi: 10.1634/theoncologist.2010-0119. Epub 2011 Jan 6.

35.

Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.

Scartozzi M, Loretelli C, Bearzi I, Mandolesi A, Galizia E, Onofri A, Pistelli M, Bittoni A, Berardi R, Cascinu S.

Ann Oncol. 2011 Apr;22(4):897-902. doi: 10.1093/annonc/mdq542. Epub 2010 Oct 6.

PMID:
20926544
36.

Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.

Scartozzi M, Bearzi I, Mandolesi A, Galizia E, Pierantoni C, Loupakis F, Berardi R, Zaniboni A, Quadri A, Zorzi F, Biagetti S, Loretelli C, Biscotti T, Labianca R, Masi G, Falcone A, Cascinu S.

Anal Quant Cytol Histol. 2009 Dec;31(6):417-23.

PMID:
20698358
37.

Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.

Scartozzi M, Mandolesi A, Giampieri R, Pierantoni C, Loupakis F, Zaniboni A, Galizia E, Giustini L, Silva RR, Bisonni R, Berardi R, Biagetti S, Menzo S, Falcone A, Bearzi I, Cascinu S.

Int J Cancer. 2010 Oct 15;127(8):1941-7. doi: 10.1002/ijc.25193.

38.

Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.

Berardi R, Maccaroni E, Onofri A, Giampieri R, Pistelli M, Bittoni A, Scartozzi M, Pierantoni C, Mandolesi A, Bearzi I, Cascinu S.

Expert Opin Pharmacother. 2009 Oct;10(15):2467-78. doi: 10.1517/14656560903143784. Review.

PMID:
19761354
39.

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.

Scartozzi M, Bearzi I, Mandolesi A, Pierantoni C, Loupakis F, Zaniboni A, Negri F, Quadri A, Zorzi F, Galizia E, Berardi R, Biscotti T, Labianca R, Masi G, Falcone A, Cascinu S.

BMC Cancer. 2009 Aug 27;9:303. doi: 10.1186/1471-2407-9-303.

40.

Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.

Berardi R, Mantello G, Scartozzi M, Del Prete S, Luppi G, Martinelli R, Fumagalli M, Grillo-Ruggieri F, Bearzi I, Mandolesi A, Marmorale C, Cascinu S.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1437-43. doi: 10.1016/j.ijrobp.2009.01.016. Epub 2009 Apr 20.

PMID:
19386440
41.

Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity.

Gasparotto D, Rossi S, Bearzi I, Doglioni C, Marzotto A, Hornick JL, Grizzo A, Sartor C, Mandolesi A, Sciot R, Debiec-Rychter M, Dei Tos AP, Maestro R.

Clin Cancer Res. 2008 Sep 15;14(18):5715-21. doi: 10.1158/1078-0432.CCR-08-0622. Epub 2008 Sep 8.

42.

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients.

Braconi C, Bracci R, Bearzi I, Bianchi F, Sabato S, Mandolesi A, Belvederesi L, Cascinu S, Valeri N, Cellerino R.

Ann Oncol. 2008 Jul;19(7):1293-8. doi: 10.1093/annonc/mdn040. Epub 2008 Mar 27.

PMID:
18372285
43.

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study.

Braconi C, Bracci R, Bearzi I, Bianchi F, Costagliola A, Catalani R, Mandolesi A, Ranaldi R, Galizia E, Cascinu S, Rossi G, Giustini L, Latini L, Valeri N, Cellerino R.

Ann Oncol. 2008 Apr;19(4):706-10. doi: 10.1093/annonc/mdm503. Epub 2008 Jan 10.

PMID:
18187489
44.

Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.

Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, Catalano V, Quadri A, Zorzi F, Berardi R, Biscotti T, Labianca R, Falcone A, Cascinu S.

J Clin Oncol. 2007 Sep 1;25(25):3930-5.

PMID:
17761976
45.

Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.

Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Pierantoni C, Cascinu S.

Br J Cancer. 2007 Jul 2;97(1):92-7. Epub 2007 Jun 19.

46.

Collagenous fibroma of the deltoid muscle: clinical, surgical and histopathological aspects.

Marinelli M, Lupetti E, Gigante A, Mandolesi A, Bearzi I, de Palma L.

J Orthop Traumatol. 2007 Jun;8(2):91-4. doi: 10.1007/s10195-007-0170-0. Epub 2007 Jun 8.

PMID:
27519894
47.

A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.

Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A.

Am J Clin Nutr. 2007 Jan;85(1):160-6.

PMID:
17209192
48.

Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma.

Goteri G, Rupoli S, Tassetti A, Pulini S, Morichetti D, Filosa A, Mandolesi A, Veccia S, Leoni P, Bearzi I.

Ann Hematol. 2006 Sep;85(9):617-9. Epub 2006 Jul 4. No abstract available.

PMID:
16821018
49.

MSH2 splice site mutation and endometrial cancer.

Bianchi F, Rosati S, Belvederesi L, Loretelli C, Catalani R, Mandolesi A, Bracci R, Bearzi I, Porfiri E, Cellerino R.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1419-23.

PMID:
16803540
50.

Gastrointestinal stromal tumor. A study of 158 cases: clinicopathological features and prognostic factors.

Bearzi I, Mandolesi A, Arduini F, Costagliola A, Ranaldi R.

Anal Quant Cytol Histol. 2006 Jun;28(3):137-47.

PMID:
16786723

Supplemental Content

Loading ...
Support Center